Greenwich Lifesciences Inc (GLSI)

$13.06 0.69 (5.02%)

16:00 EDT GLSI Stock Quote Delayed 30 Minutes

GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023

By InvestorPlace Earnings Apr 15, 2024

GLSI stock results show that Greenwich LifeSciences missed analyst estimates for earnings per share the fourth quarter of 2023.

GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week

TOPS, SURG: The Top 5 Short Squeeze Stocks This Week

GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week

More Articles

Volume:

Previous Close -

Market Cap 1.37B

PE Ratio -9.67

EPS -1.35

Volume (Avg. Vol.) 16,576

Day's Range $12.98 - $14.17

52-Week Range $7.58 - $21.44

Dividend & Yield N/A (N/A)

GLSI Stock Predictions, Articles, and Greenwich Lifesciences Inc News

From InvestorPlace
From the Web

NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week

By William White, InvestorPlace Writer Sep 19, 2022

Traders continue to show interest in short squeeze stocks this week as they seek out likely targets that will run higher.

ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week

By William White, InvestorPlace Writer Sep 12, 2022

We're starting off another week with a deep dive into the short squeeze stocks traders are going to want to keep an eye on!

MICS, REV: The Top 5 Short Squeeze Stocks to Watch This Week

By William White, InvestorPlace Writer Aug 22, 2022

Investors looking for the most likely short squeeze stocks to watch this week are in the right place with a list of the top five to watch!

7 Short-Term Stocks to Buy for a Quick Profit

By Josh Enomoto, InvestorPlace Contributor Aug 8, 2022

Although the market has been volatile this year, the wildness also creates opportunities for short-term stocks to buy for a quick profit.

Why Is Greenwich Lifesciences (GLSI) Stock Up Today?

By William White, InvestorPlace Writer Jul 12, 2022

Greenwich Lifesciences (GLSI) stock is heading higher on Tuesday after the FDA lifted a hold on a Phase III clinical trial.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning

By William White, InvestorPlace Writer Apr 15, 2021

It's Thursday morning and investors keeping track of the pre-market will want to make sure they check out this list of movers!

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Monday Morning

By Robert Lakin, InvestorPlace Contributor Apr 12, 2021

Get ready for the trading week by diving into today's biggest pre-market movers. Here are the top gainers and losers on Monday morning.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Friday Morning

By William White, InvestorPlace Writer Apr 9, 2021

The end of the week is quickly approaching but investors can't relax yet and we're here to help with Friday's biggest pre-market movers.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

By William White, InvestorPlace Writer Apr 7, 2021

We're only halfway through the week but there's plenty of pre-market movers that investors will want to keep an eye on today.

Greenwich LifeSciences Is Both a Sound Investment and a Feel-Good Buy

By David Moadel, InvestorPlace Contributor Apr 2, 2021

Greenwich LifeSciences is advancing cancer treatments with life-changing potential, and recent developments should boost GLSI stock's value.

GLSI Stock: Why Greenwich LifeSciences Is Skyrocketing Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Mar 8, 2021

GLSI stock is skyrocketing again on Monday after the company appointed Dr. Jaye Thompson to run its Phase 3 clinical trials.

GLSI Stock: Why Greenwich LifeSciences Is Up 2,000% Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Dec 9, 2020

GLSI stock is soaring Wednesday after Greenwich LifeSciences shared promising results from its breast cancer immunothrapy.

Greenwich LifeSciences stock jumps 8% on Phase 3 study expansion (NASDAQ:GLSI)

From Seeking Alpha Feb 27, 2024

Greenwich LifeSciences (GLSI) stock jumped 8% after the biotech company said it has received approval to expand a Phase 3 study of its drug GSLI-100 in Europe. Read more here.

Greenwich Lifesciences announces acceptance for Flamingo-01 trial by EMA (NASDAQ:GLSI)

From Seeking Alpha Feb 22, 2024

Greenwich LifeSciences receives approval from European Medicines Agency for expansion of Flamingo-01 clinical trial in Europe, marking a significant...

Analysts Offer Insights on Healthcare Companies: Evofem Biosciences (OtherEVFM), Greenwich LifeSciences (GLSI) and Chinook Therapeutics (KDNY)

From TipRanks Aug 15, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Evofem Biosciences (

H.C. Wainwright Thinks Greenwich LifeSciences’ Stock is Going to Recover

From TipRanks Jul 12, 2022

H.C. Wainwright analyst Yi Chen reitera...

H.C. Wainwright Reiterates Their Buy Rating on Greenwich LifeSciences (GLSI)

From TipRanks Jun 1, 2022

H.C. Wainwright analyst Yi Chen reitera...

12 Health Care Stocks Moving In Wednesday's After-Market Session

From Benzinga Jun 2, 2021

Gainers Tilray (NASDAQ:TLRY) shares incre...

ADVERTISEMENT